Clinical inertia in insulin initiation in type 2 diabetes across Central and Southeastern Europe

Excerpt

We read with interest the article by Campbell et al. [1]: “High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study” that has recently been published online in Acta Diabetologica. The authors investigated the level of clinical inertia in insulin initiation in type 2 diabetes mellitus in the region. The most important findings were that only 9.4% (20 of out of 211 respondents) of healthcare professionals would initiate insulin therapy in T2D patients at the recommended HbA1c threshold of 7–7.9% (53–63 mmol/mol), with psychological distress being recorded as the major barrier to insulin initiation. The authors concluded that despite the large regional variation, there is a widespread delay of insulin initiation from specialist diabetes healthcare professionals in Central and Southeastern Europe. …